Company: CDLX
Filing Date: 2025-04-03
Form Type: ARS
Source: 0001666071-25-000048
Chunk: 165

Company: Cardlytics, Inc.
Filing Date: 2025-04-03
Form: ARS
Chunk 165
---
31, 2024. PART IV. 107

ITEM 15. EXHIBIT AND FINANCIAL STATEMENT SCHEDULES (a) The following documents are filed as part of this Annual Report: (i) Consolidated Financial Statements and Reports of Independent Registered Public Accounting Firm are shown in the Index to Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K. (ii) All financial statement schedules are omitted because they are not applicable or the required information is shown in the financial statements or notes thereto. (iii) Exhibits are incorporated herein by reference or are filed with this Annual Report as indicated below. (b) Exhibits: Incorporated by Reference Exhibit Exhibit Description Schedule /Form File Number Exhibit Filing Date 3.1 Amended and Restated Certificate of Incorporation of the Registrant S-1 333-222531 3.2 1/12/2018 3.2 Amended and Restated Bylaws of the Registrant S-1 333-222531 3.4 1/12/2018 4.1 Form of Common Stock Certificate of the Registrant S-1/A 333-222531 4.1 1/29/2018 4.2 Description of Cardlytics, Inc. Common Stock 10-K 001-38386 4.3 3/3/2020 4.3 Indenture, dated as of September 22, 2020, by and between the Registrant ant U.S. Bank National Association, as Trustee. 8-K 001-38386 4.1 9/22/2020 4.4 Form of Global Note, representing the Registrant’s 1.00% Convertible Senior Notes due 2025 (included as Exhibit A to the Indenture filed as Exhibit 4.4) 8-K 001-38386 4.2 9/22/2020 4.5 Indenture, dated as of April 1, 2024, by and between the Registrant ant U.S. Bank National Association, as Trustee. 8-K 001-38386 4.1 4/1/2024 4.6 Form of Global Note, representing the Registrant’s 4.25% Convertible Senior Notes due 2029 (included as Exhibit A to the Indenture filed as Exhibit 4.6